Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Dec, 2017 | Pages:
102 | Publisher: QYResearch
Industry: Pharmaceutical | Report Format: Electronic (PDF)
In this report, the EMEA Porcine Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Doses), revenue (Million USD), market share and growth rate of Porcine Vaccine for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.
EMEA Porcine Vaccine market competition by top manufacturers/players, with Porcine Vaccine sales volume (K Doses), price (USD/Dose), revenue (Million USD) and market share for each manufacturer/player; the top players including
Bayer AG.
Bimeda Animal Health
Boehringer Ingelheim GmbH
Ceva Sante Animale
Eli Lilly
Merck & Co., Inc.
Merial (Sanofi)
Vetoquinol
Zoetis, Inc.
On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Inactivated Vaccines
Live Attenuated Vaccines
Toxoid Vaccines
Recombinant Vaccines
Conjugate Vaccines
DNA Vaccines
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Veterinary Hospitals
Hog/Pig Production Farm
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
EMEA (Europe, Middle East and Africa) Porcine Vaccine Market Report 2017
1 Porcine Vaccine Overview
1.1 Product Overview and Scope of Porcine Vaccine
1.2 Classification of Porcine Vaccine
1.2.1 EMEA Porcine Vaccine Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Porcine Vaccine Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Inactivated Vaccines
1.2.4 Live Attenuated Vaccines
1.2.5 Toxoid Vaccines
1.2.6 Recombinant Vaccines
1.2.7 Conjugate Vaccines
1.2.8 DNA Vaccines
1.3 EMEA Porcine Vaccine Market by Application/End Users
1.3.1 EMEA Porcine Vaccine Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.2 Veterinary Hospitals
1.3.3 Hog/Pig Production Farm
1.4 EMEA Porcine Vaccine Market by Region
1.4.1 EMEA Porcine Vaccine Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Porcine Vaccine (2012-2022)
1.5.1 EMEA Porcine Vaccine Sales and Growth Rate (2012-2022)
1.5.2 EMEA Porcine Vaccine Revenue and Growth Rate (2012-2022)
2 EMEA Porcine Vaccine Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Porcine Vaccine Market Competition by Players/Manufacturers
2.1.1 EMEA Porcine Vaccine Sales Volume and Market Share of Major Players (2012-2017)
2.1.2 EMEA Porcine Vaccine Revenue and Share by Players (2012-2017)
2.1.3 EMEA Porcine Vaccine Sale Price by Players (2012-2017)
2.2 EMEA Porcine Vaccine (Volume and Value) by Type/Product Category
2.2.1 EMEA Porcine Vaccine Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Porcine Vaccine Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Porcine Vaccine Sale Price by Type (2012-2017)
2.3 EMEA Porcine Vaccine (Volume) by Application
2.4 EMEA Porcine Vaccine (Volume and Value) by Region
2.4.1 EMEA Porcine Vaccine Sales and Market Share by Region (2012-2017)
2.4.2 EMEA Porcine Vaccine Revenue and Market Share by Region (2012-2017)
2.4.3 EMEA Porcine Vaccine Sales Price by Region (2012-2017)
3 Europe Porcine Vaccine (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Porcine Vaccine Sales and Value (2012-2017)
3.1.1 Europe Porcine Vaccine Sales Volume and Growth Rate (2012-2017)
3.1.2 Europe Porcine Vaccine Revenue and Growth Rate (2012-2017)
3.2 Europe Porcine Vaccine Sales and Market Share by Type
3.3 Europe Porcine Vaccine Sales and Market Share by Application
3.4 Europe Porcine Vaccine Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Porcine Vaccine Sales Volume by Countries (2012-2017)
3.4.2 Europe Porcine Vaccine Revenue by Countries (2012-2017)
3.4.3 Germany Porcine Vaccine Sales and Growth Rate (2012-2017)
3.4.4 France Porcine Vaccine Sales and Growth Rate (2012-2017)
3.4.5 UK Porcine Vaccine Sales and Growth Rate (2012-2017)
3.4.6 Russia Porcine Vaccine Sales and Growth Rate (2012-2017)
3.4.7 Italy Porcine Vaccine Sales and Growth Rate (2012-2017)
3.4.8 Benelux Porcine Vaccine Sales and Growth Rate (2012-2017)
4 Middle East Porcine Vaccine (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Porcine Vaccine Sales and Value (2012-2017)
4.1.1 Middle East Porcine Vaccine Sales Volume and Growth Rate (2012-2017)
4.1.2 Middle East Porcine Vaccine Revenue and Growth Rate (2012-2017)
4.2 Middle East Porcine Vaccine Sales and Market Share by Type
4.3 Middle East Porcine Vaccine Sales and Market Share by Application
4.4 Middle East Porcine Vaccine Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Porcine Vaccine Sales Volume by Countries (2012-2017)
4.4.2 Middle East Porcine Vaccine Revenue by Countries (2012-2017)
4.4.3 Saudi Arabia Porcine Vaccine Sales and Growth Rate (2012-2017)
4.4.4 Israel Porcine Vaccine Sales and Growth Rate (2012-2017)
4.4.5 UAE Porcine Vaccine Sales and Growth Rate (2012-2017)
4.4.6 Iran Porcine Vaccine Sales and Growth Rate (2012-2017)
5 Africa Porcine Vaccine (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Porcine Vaccine Sales and Value (2012-2017)
5.1.1 Africa Porcine Vaccine Sales Volume and Growth Rate (2012-2017)
5.1.2 Africa Porcine Vaccine Revenue and Growth Rate (2012-2017)
5.2 Africa Porcine Vaccine Sales and Market Share by Type
5.3 Africa Porcine Vaccine Sales and Market Share by Application
5.4 Africa Porcine Vaccine Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Porcine Vaccine Sales Volume by Countries (2012-2017)
5.4.2 Africa Porcine Vaccine Revenue by Countries (2012-2017)
5.4.3 South Africa Porcine Vaccine Sales and Growth Rate (2012-2017)
5.4.4 Nigeria Porcine Vaccine Sales and Growth Rate (2012-2017)
5.4.5 Egypt Porcine Vaccine Sales and Growth Rate (2012-2017)
5.4.6 Algeria Porcine Vaccine Sales and Growth Rate (2012-2017)
6 EMEA Porcine Vaccine Manufacturers/Players Profiles and Sales Data
6.1 Bayer AG.
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Porcine Vaccine Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Bayer AG. Porcine Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Bimeda Animal Health
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Porcine Vaccine Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Bimeda Animal Health Porcine Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Boehringer Ingelheim GmbH
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Porcine Vaccine Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Boehringer Ingelheim GmbH Porcine Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Ceva Sante Animale
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Porcine Vaccine Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Ceva Sante Animale Porcine Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Eli Lilly
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Porcine Vaccine Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Eli Lilly Porcine Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Merck & Co., Inc.
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Porcine Vaccine Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Merck & Co., Inc. Porcine Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Merial (Sanofi)
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Porcine Vaccine Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Merial (Sanofi) Porcine Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Vetoquinol
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Porcine Vaccine Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Vetoquinol Porcine Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Zoetis, Inc.
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Porcine Vaccine Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Zoetis, Inc. Porcine Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
7 Porcine Vaccine Manufacturing Cost Analysis
7.1 Porcine Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Porcine Vaccine
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Porcine Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Porcine Vaccine Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 EMEA Porcine Vaccine Market Forecast (2017-2022)
11.1 EMEA Porcine Vaccine Sales, Revenue and Price Forecast (2017-2022)
11.1.1 EMEA Porcine Vaccine Sales and Growth Rate Forecast (2017-2022)
11.1.2 EMEA Porcine Vaccine Revenue and Growth Rate Forecast (2017-2022)
11.1.3 EMEA Porcine Vaccine Price and Trend Forecast (2017-2022)
11.2 EMEA Porcine Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Porcine Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Porcine Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Porcine Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Porcine Vaccine Sales Forecast by Type (2017-2022)
11.7 EMEA Porcine Vaccine Sales Forecast by Application (2017-2022)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Porcine Vaccine
Figure EMEA Porcine Vaccine Sales Volume (K Doses) by Type (2012-2022)
Figure EMEA Porcine Vaccine Sales Volume Market Share by Type (Product Category) in 2016
Figure Inactivated Vaccines Product Picture
Figure Live Attenuated Vaccines Product Picture
Figure Toxoid Vaccines Product Picture
Figure Recombinant Vaccines Product Picture
Figure Conjugate Vaccines Product Picture
Figure DNA Vaccines Product Picture
Figure EMEA Porcine Vaccine Sales Volume (K Doses) by Application (2012-2022)
Figure EMEA Sales Market Share of Porcine Vaccine by Application in 2016
Figure Veterinary Hospitals Examples
Table Key Downstream Customer in Veterinary Hospitals
Figure Hog/Pig Production Farm Examples
Table Key Downstream Customer in Hog/Pig Production Farm
Figure EMEA Porcine Vaccine Market Size (Million USD) by Region (2012-2022)
Figure Europe Porcine Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Porcine Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Porcine Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Porcine Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure Africa Porcine Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Porcine Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Porcine Vaccine Sales Volume and Growth Rate (2012-2022)
Figure EMEA Porcine Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Porcine Vaccine Market Major Players Product Sales Volume (K Doses) (2012-2017)
Table EMEA Porcine Vaccine Sales Volume (K Doses) of Major Players (2012-2017)
Table EMEA Porcine Vaccine Sales Share by Players (2012-2017)
Figure 2016 Porcine Vaccine Sales Share by Players
Figure 2017 Porcine Vaccine Sales Share by Players
Figure EMEA Porcine Vaccine Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Porcine Vaccine Revenue (Million USD) by Players (2012-2017)
Table EMEA Porcine Vaccine Revenue Share by Players (2012-2017)
Table 2016 EMEA Porcine Vaccine Revenue Share by Players
Table 2017 EMEA Porcine Vaccine Revenue Share by Players
Table EMEA Porcine Vaccine Sale Price (USD/Dose) by Players (2012-2017)
Table EMEA Porcine Vaccine Sales (K Doses) and Market Share by Type (2012-2017)
Table EMEA Porcine Vaccine Sales Share by Type (2012-2017)
Figure Sales Market Share of Porcine Vaccine by Type (2012-2017)
Figure EMEA Porcine Vaccine Sales Market Share by Type (2012-2017)
Table EMEA Porcine Vaccine Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Porcine Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Porcine Vaccine by Type in 2016
Table EMEA Porcine Vaccine Sale Price (USD/Dose) by Type (2012-2017)
Table EMEA Porcine Vaccine Sales (K Doses) and Market Share by Application (2012-2017)
Table EMEA Porcine Vaccine Sales Share by Application (2012-2017)
Figure Sales Market Share of Porcine Vaccine by Application (2012-2017)
Figure EMEA Porcine Vaccine Sales Market Share by Application in 2016
Table EMEA Porcine Vaccine Sales (K Doses) and Market Share by Region (2012-2017)
Table EMEA Porcine Vaccine Sales Share by Region (2012-2017)
Figure Sales Market Share of Porcine Vaccine by Region (2012-2017)
Figure EMEA Porcine Vaccine Sales Market Share in 2016
Table EMEA Porcine Vaccine Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Porcine Vaccine Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Porcine Vaccine by Region (2012-2017)
Figure EMEA Porcine Vaccine Revenue Market Share Regions in 2016
Table EMEA Porcine Vaccine Sales Price (USD/Dose) by Region (2012-2017)
Figure Europe Porcine Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Europe Porcine Vaccine Revenue and Growth Rate (2012-2017)
Table Europe Porcine Vaccine Sales (K Doses) by Type (2012-2017)
Table Europe Porcine Vaccine Market Share by Type (2012-2017)
Figure Europe Porcine Vaccine Market Share by Type in 2016
Table Europe Porcine Vaccine Sales (K Doses) by Application (2012-2017)
Table Europe Porcine Vaccine Market Share by Application (2012-2017)
Figure Europe Porcine Vaccine Market Share by Application in 2016
Table Europe Porcine Vaccine Sales (K Doses) by Countries (2012-2017)
Table Europe Porcine Vaccine Sales Market Share by Countries (2012-2017)
Figure Europe Porcine Vaccine Sales Market Share by Countries (2012-2017)
Figure Europe Porcine Vaccine Sales Market Share by Countries in 2016
Table Europe Porcine Vaccine Revenue (Million USD) by Countries (2012-2017)
Table Europe Porcine Vaccine Revenue Market Share by Countries (2012-2017)
Figure Europe Porcine Vaccine Revenue Market Share by Countries (2012-2017)
Figure Europe Porcine Vaccine Revenue Market Share by Countries in 2016
Figure Germany Porcine Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure France Porcine Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure UK Porcine Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Russia Porcine Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Italy Porcine Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Benelux Porcine Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Middle East Porcine Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Middle East Porcine Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Porcine Vaccine Sales (K Doses) by Type (2012-2017)
Table Middle East Porcine Vaccine Market Share by Type (2012-2017)
Figure Middle East Porcine Vaccine Market Share by Type (2012-2017)
Table Middle East Porcine Vaccine Sales (K Doses) by Applications (2012-2017)
Table Middle East Porcine Vaccine Market Share by Applications (2012-2017)
Figure Middle East Porcine Vaccine Sales Market Share by Application in 2016
Table Middle East Porcine Vaccine Sales Volume (K Doses) by Countries (2012-2017)
Table Middle East Porcine Vaccine Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Porcine Vaccine Sales Volume Market Share by Countries in 2016
Table Middle East Porcine Vaccine Revenue (Million USD) by Countries (2012-2017)
Table Middle East Porcine Vaccine Revenue Market Share by Countries (2012-2017)
Figure Middle East Porcine Vaccine Revenue Market Share by Countries (2012-2017)
Figure Middle East Porcine Vaccine Revenue Market Share by Countries in 2016
Figure Saudi Arabia Porcine Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Israel Porcine Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure UAE Porcine Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Iran Porcine Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Africa Porcine Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Africa Porcine Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Porcine Vaccine Sales (K Doses) by Type (2012-2017)
Table Africa Porcine Vaccine Sales Market Share by Type (2012-2017)
Figure Africa Porcine Vaccine Sales Market Share by Type (2012-2017)
Figure Africa Porcine Vaccine Sales Market Share by Type in 2016
Table Africa Porcine Vaccine Sales (K Doses) by Application (2012-2017)
Table Africa Porcine Vaccine Sales Market Share by Application (2012-2017)
Figure Africa Porcine Vaccine Sales Market Share by Application (2012-2017)
Table Africa Porcine Vaccine Sales Volume (K Doses) by Countries (2012-2017)
Table Africa Porcine Vaccine Sales Market Share by Countries (2012-2017)
Figure Africa Porcine Vaccine Sales Market Share by Countries (2012-2017)
Figure Africa Porcine Vaccine Sales Market Share by Countries in 2016
Table Africa Porcine Vaccine Revenue (Million USD) by Countries (2012-2017)
Table Africa Porcine Vaccine Revenue Market Share by Countries (2012-2017)
Figure Africa Porcine Vaccine Revenue Market Share by Countries (2012-2017)
Figure Africa Porcine Vaccine Revenue Market Share by Countries in 2016
Figure South Africa Porcine Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Nigeria Porcine Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Egypt Porcine Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Algeria Porcine Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Table Bayer AG. Porcine Vaccine Basic Information List
Table Bayer AG. Porcine Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Bayer AG. Porcine Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Bayer AG. Porcine Vaccine Sales Market Share in EMEA (2012-2017)
Figure Bayer AG. Porcine Vaccine Revenue Market Share in EMEA (2012-2017)
Table Bimeda Animal Health Porcine Vaccine Basic Information List
Table Bimeda Animal Health Porcine Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Bimeda Animal Health Porcine Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Bimeda Animal Health Porcine Vaccine Sales Market Share in EMEA (2012-2017)
Figure Bimeda Animal Health Porcine Vaccine Revenue Market Share in EMEA (2012-2017)
Table Boehringer Ingelheim GmbH Porcine Vaccine Basic Information List
Table Boehringer Ingelheim GmbH Porcine Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim GmbH Porcine Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Boehringer Ingelheim GmbH Porcine Vaccine Sales Market Share in EMEA (2012-2017)
Figure Boehringer Ingelheim GmbH Porcine Vaccine Revenue Market Share in EMEA (2012-2017)
Table Ceva Sante Animale Porcine Vaccine Basic Information List
Table Ceva Sante Animale Porcine Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Ceva Sante Animale Porcine Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Ceva Sante Animale Porcine Vaccine Sales Market Share in EMEA (2012-2017)
Figure Ceva Sante Animale Porcine Vaccine Revenue Market Share in EMEA (2012-2017)
Table Eli Lilly Porcine Vaccine Basic Information List
Table Eli Lilly Porcine Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Eli Lilly Porcine Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Eli Lilly Porcine Vaccine Sales Market Share in EMEA (2012-2017)
Figure Eli Lilly Porcine Vaccine Revenue Market Share in EMEA (2012-2017)
Table Merck & Co., Inc. Porcine Vaccine Basic Information List
Table Merck & Co., Inc. Porcine Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Merck & Co., Inc. Porcine Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Merck & Co., Inc. Porcine Vaccine Sales Market Share in EMEA (2012-2017)
Figure Merck & Co., Inc. Porcine Vaccine Revenue Market Share in EMEA (2012-2017)
Table Merial (Sanofi) Porcine Vaccine Basic Information List
Table Merial (Sanofi) Porcine Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Merial (Sanofi) Porcine Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Merial (Sanofi) Porcine Vaccine Sales Market Share in EMEA (2012-2017)
Figure Merial (Sanofi) Porcine Vaccine Revenue Market Share in EMEA (2012-2017)
Table Vetoquinol Porcine Vaccine Basic Information List
Table Vetoquinol Porcine Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Vetoquinol Porcine Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Vetoquinol Porcine Vaccine Sales Market Share in EMEA (2012-2017)
Figure Vetoquinol Porcine Vaccine Revenue Market Share in EMEA (2012-2017)
Table Zoetis, Inc. Porcine Vaccine Basic Information List
Table Zoetis, Inc. Porcine Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Zoetis, Inc. Porcine Vaccine Sales (K Doses) and Growth Rate (2012-2017)
Figure Zoetis, Inc. Porcine Vaccine Sales Market Share in EMEA (2012-2017)
Figure Zoetis, Inc. Porcine Vaccine Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Porcine Vaccine
Figure Manufacturing Process Analysis of Porcine Vaccine
Figure Porcine Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Porcine Vaccine Major Manufacturers in 2016
Table Major Buyers of Porcine Vaccine
Table Distributors/Traders List
Figure EMEA Porcine Vaccine Sales (K Doses) and Growth Rate Forecast (2017-2022)
Figure EMEA Porcine Vaccine Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Porcine Vaccine Price (USD/Dose) and Trend Forecast (2017-2022)
Table EMEA Porcine Vaccine Sales (K Doses) Forecast by Region (2017-2022)
Figure EMEA Porcine Vaccine Sales Market Share Forecast by Region (2017-2022)
Table EMEA Porcine Vaccine Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Porcine Vaccine Revenue Market Share Forecast by Region (2017-2022)
Table Europe Porcine Vaccine Sales (K Doses) Forecast by Countries (2017-2022)
Figure Europe Porcine Vaccine Sales Market Share Forecast by Countries (2017-2022)
Table Europe Porcine Vaccine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Porcine Vaccine Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Porcine Vaccine Sales (K Doses) Forecast by Countries (2017-2022)
Figure Middle East Porcine Vaccine Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Porcine Vaccine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Porcine Vaccine Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Porcine Vaccine Sales (K Doses) Forecast by Countries (2017-2022)
Figure Africa Porcine Vaccine Sales Market Share Forecast by Countries (2017-2022)
Table Africa Porcine Vaccine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Porcine Vaccine Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Porcine Vaccine Sales (K Doses) Forecast by Type (2017-2022)
Figure EMEA Porcine Vaccine Sales Market Share Forecast by Type (2017-2022)
Table EMEA Porcine Vaccine Sales (K Doses) Forecast by Application (2017-2022)
Figure EMEA Porcine Vaccine Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
